Good MorningEquity markets advanced on Wednesday, setting a new three months ahead of the Thanksgiving Holiday. The move is partly due to a gain in Microsoft driven by the reinstatement of Sam Altman to the held of OpenAI. Shares of Microsoft moved up to set a new all-time high on the news and could head higher. The company is establishing itself as a rival to AI powerhouse NVIDIA and will likely build on the momentum gained in 2023.
The S&P 500 closed with a gain near 0.5%, but the move wasn't strong. The index tests resistance at a critical level and has difficulty advancing above it. If the market doesn't commit soon, bearish traders could come back to the market. In this scenario, the index is capped at critical levels and below the all-time high, where it is likely to remain range-bound. With the holiday shopping season looking like a bust, it's unlikely the S&P 500 will set new highs soon without a change to the fundamentals. That won't come without a change in the FOMC policy stance, which isn't likely until next year. Featured: Wall Street’s quietly buying these 3 AI infrastructure plays (Ad) 
|
Finance | |
Small-cap stocks are finally staging a comeback after underperforming against medium to large-cap stocks this year.
This year's notable trend has been the significant outperformance of large-cap stocks, specifically those in the technology sector, versus small-cap stocks. However, with the iShar... Read the Full Story |
|
From Our Partners | | BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. | | Get the name, the ticker, and exactly how to buy it |
|
Retail/Wholesale | |
In the past month, consumer discretionary stocks have been on a tear, with the Consumer Discretionary Select Sector SPDR Fund (NYSEARCA: XLY) returning 10.47%. That led all sectors except technology stocks during that time.
In the past month, the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) return... Read the Full Story |
|
Markets | |
Don't be surprised if you see many shoppers at The Gap Inc. (NYSE: GPS) this holiday season.
Why?
The retailer is crushing it.
Well, sort of.
On Friday, the company behind Old Navy, Banana Republic, Athleta and Gap stores reported third-quarter earnings per share (EPS) of 59 cents, nearly t... Read the Full Story |
|
From Our Partners | | See the Signals Most Traders Miss
We monitor subtle shifts in order flow, volume patterns, and early trend behavior.
Stock News Trends highlights moves long before they hit mainstream screens. | | Join Free — Start Tracking Early Market Data |
|
Technology | |
Value is where you find it. Today, you can find it with Tower Semiconductor Ltd. (NASDAQ: TSEM), Johnson Controls International PLC (NYSE: JCI), Barnes Group Inc. (NYSE: B) and Howard Hughes Holdings Inc. (NYSE: HHH).
These companies trade at a significant discount to the analysts' target range ... Read the Full Story |
|
Construction | |
Few sectors have impressed as significantly as the homebuilder sector in recent weeks. The SPDR S&P Homebuilders ETF (NYSE: XHB) has risen over 16% over the last month. That performance is enough to outpace the overall market, which has risen 7%, and the technology sector, which has risen 12% ... Read the Full Story |
|
From Our Partners | | With OpenAI and Anthropic moving closer to the IPO spotlight, AI excitement could spill into several public-market sectors this summer - and most investors may chase the obvious names too late.
A free report identifies 7 stocks positioned around themes that could matter most this summer: AI infrastructure, energy demand, travel, entertainment, home improvement, and more. Built for a market where leadership may rotate quickly. | | Download 7 Best Stocks to Own in Summer 2026 for free |
|
Finance | |
The financial sector, particularly bank stocks, has been on a tear lightly, clawing back losses from the year and edging into positive territory. So far during the quarter, the financial sector has proven to be an outperforming sector.
Bank stocks surged last week following a significant rally f... Read the Full Story |
|
Medical | |
After two years of correction and downtrend, providing ample incentive to buyers all along the way, medical device maker Medtronic (NYSE: MDT) has finally reached its bottom, and the reversal is on. The Q2 results confirm normalization in the wake of the COVID bubble and a solid trajectory for gro... Read the Full Story |
|
Retail/Wholesale | |
Whether Lowe's (NYSE: LOW) or Home Depot (NYSE: HD) is the better buy is pointless because both are high-quality retail names entrenched in the consumer landscape and pay great dividends. The question is, what kind of time horizon are we talking about? Each stock has different qualities to offer i... Read the Full Story |
|
Retail/Wholesale | |
The recent third-quarter financial report for Lowe's Companies (NYSE: LOW) has unfurled a complex web of financial triumphs and challenges. Despite exceeding market projections, Lowe's faced a drop in total revenues, starkly contrasting with anticipated figures. This stumble was magnified by a sta... Read the Full Story |
|
Technology | |
The stock market is the ultimate emotional and intellectual challenge. You can develop skills beyond most people's understanding, such as making independent judgments on a situation, even if it means going against your bare instincts. Today, NVIDIA (NASDAQ: NVDA) trains that contrarian muscle in y... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts. | | View Today's Stock Pick |
|
